Amundi
TMO icon

Amundi’s Thermo Fisher Scientific TMO Stock Holding History

Amundi’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$909M Sell
1,813,091
-203,169
-10% -$97.5M 0.22% 78
2026
Q1 		$991M Buy
2,016,260
+369,238
+22% +$200M 0.27% 68
2025
Q4 		$954M Buy
1,647,022
+60,021
+4% +$33.9M 0.26% 82
2025
Q3 		$863M Sell
1,587,001
-792,205
-33% -$369M 0.28% 69
2025
Q2 		$1.02B Sell
2,379,206
-649,838
-21% -$272M 0.35% 58
2025
Q1 		$1.43B Buy
3,029,044
+168,197
+6% +$91.1M 0.52% 33
2024
Q4 		$1.56B Buy
2,860,847
+340,263
+13% +$187M 0.54% 27
2024
Q3 		$1.5B Buy
2,520,584
+146,491
+6% +$86.7M 0.55% 32
2024
Q2 		$1.27B Buy
2,374,093
+169,615
+8% +$97.2M 0.49% 38
2024
Q1 		$1.2B Sell
2,204,478
-287,717
-12% -$161M 0.51% 29
2023
Q4 		$1.35B Sell
2,492,195
-410,134
-14% -$199M 0.61% 23
2023
Q3 		$1.4B Buy
2,902,329
+60,438
+2% +$32.2M 0.69% 20
2023
Q2 		$1.48B Buy
2,841,891
+24,977
+0.9% +$13.5M 0.75% 16
2023
Q1 		$1.63B Sell
2,816,914
-313,372
-10% -$177M 0.88% 14
2022
Q4 		$1.82B Buy
3,130,286
+157,303
+5% +$83.4M 1% 10
2022
Q3 		$1.62B Buy
2,972,983
+1,114,425
+60% +$624M 0.96% 12
2022
Q2 		$979M Sell
1,858,558
-86,783
-4% -$47.8M 0.79% 21
2022
Q1 		$1.19B Sell
1,945,341
-10,216
-0.5% -$5.87M 0.8% 17
2021
Q4 		$1.18B Sell
1,955,557
-133,270
-6% -$83.2M 0.75% 19
2021
Q3 		$1.19B Buy
2,088,827
+317,108
+18% +$174M 0.84% 14
2021
Q2 		$894M Buy
+1,771,719
New +$836M 0.62% 28

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Amundi's TMO Position: Q2 2026 in Review

Amundi reduced its Thermo Fisher Scientific (TMO) stake by 10% in Q2 2026, selling an estimated $97.5M and leaving 1,813,091 shares worth $909M. The position accounts for 0.22% of the portfolio, ranked #78.

Amundi first reported a position in TMO in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.82B in Q4 2022. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Amundi held 1,813,091 shares of Thermo Fisher Scientific worth $909M as of Q2 2026.
  • Amundi sold 203,169 Thermo Fisher Scientific shares in Q2 2026, an estimated $97.5M.
  • Thermo Fisher Scientific made up 0.22% of Amundi's portfolio in Q2 2026, its #78 holding.
  • Amundi first reported a position in Thermo Fisher Scientific in Q2 2021 and has held it in 21 quarters since.
  • Amundi's Thermo Fisher Scientific position peaked at $1.82B in Q4 2022.
  • 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.